Interaksi Benazepril dan hidroklorotiazid dan Moeksipril

Benazepril dan hidroklorotiazid dan Moeksipril: kedua label peresepan menandai kombinasi ini dengan bahasa yang paling tegas, seperti kontraindikasi, peringatan kotak hitam, atau instruksi untuk menghindarinya.

Mayor

Jangan dikombinasikan tanpa arahan dokter yang meresepkan. Bahasa label di bawah ini adalah yang paling tegas yang digunakan FDA.

Apa kata label FDA

Dari label Benazepril dan hidroklorotiazid (Lotensin HCT) · berlaku sejak 2026-02-24

Mayor

Lotensin HCT is also contraindicated in patients who are hypersensitive to benazepril, to any other ACE inhibitor, to hydrochlorothiazide, or to other sulfonamide-derived drugs.

Kontraindikasiberdasarkan golongan obatLihat label di DailyMed
Moderat

Like other ACE inhibitors, benazepril has been only rarely associated with hypotension in uncomplicated hypertensive patients.

Peringatanberdasarkan golongan obatLihat label di DailyMed
Moderat

The thiazide component of Lotensin HCT may potentiate the action of other antihypertensive drugs, especially ganglionic or peripheral adrenergic-blocking drugs.

Peringatanberdasarkan golongan obatLihat label di DailyMed
Moderat

Other ACE inhibitors have had less than additive effects with beta-adrenergic blockers, presumably because drugs of both classes lower blood pressure by inhibiting parts of the renin-angiotensin system.

Interaksi obatberdasarkan golongan obatLihat label di DailyMed
Minor

Lotensin HCT should be used cautiously in patients receiving concomitant therapy with other antihypertensives.

Peringatanberdasarkan golongan obatLihat label di DailyMed

Dari label Moeksipril (Moexipril Hydrochloride) · berlaku sejak 2026-01-23

Moderat

Hypotension Moexipril hydrochloride can cause symptomatic hypotension, although, as with other ACE inhibitors, this is unusual in uncomplicated hypertensive patients treated with moexipril hydrochloride alone.

Peringatanberdasarkan golongan obatLihat label di DailyMed
Moderat

Symptomatic hypotension is most likely to occur in patients who have been salt- and volume- depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting.

Peringatanberdasarkan golongan obatLihat label di DailyMed
Moderat

Volume- and salt-depletion should be corrected and, in general, diuretics stopped, before initiating therapy with moexipril hydrochloride (see PRECAUTIONS, Drug Interactions , and ADVERSE REACTIONS ).

Peringatanberdasarkan golongan obatLihat label di DailyMed
Moderat

In these patients, moexipril hydrochloride therapy should be started under close medical supervision, and patients should be followed closely for the first two weeks of treatment and whenever the dose of moexipril or an accompanying diuretic is increased.

Peringatanberdasarkan golongan obatLihat label di DailyMed
Moderat

Although there were no instances of severe neutropenia (absolute neutrophil count < 500/mm 3 ) among patients given moexipril hydrochloride, as with other ACE inhibitors, monitoring of white blood cell counts should be considered for patients who have collagen-vascular disease, especially if the disease is associated with impaired renal function.

Peringatanberdasarkan golongan obatLihat label di DailyMed

Menggunakan lebih dari dua obat ini? Interaksi saling bertumpuk. Periksa seluruh daftar Anda sekaligus; daftar itu tetap berada di peramban Anda.

Buka di pemeriksa

Bukan nasihat medis. Interaction Checker mengutip teks label FDA dan lembar fakta NIH. Penting atau tidaknya suatu interaksi bagi Anda bergantung pada dosis, waktu penggunaan, fungsi ginjal dan hati, serta kondisi lain. Pastikan dengan apoteker atau dokter yang meresepkan.